Web Exclusives

FDA approves drug for rare lung disease

On May 28, the U.S. Food and Drug Administration (FDA) approved Rapamune (sirolimus), to treat lymphangioleiomyomatosis, a rare, progressive lung disease that primarily affects…

Effects of patient migration in bed

Patient migration to the foot of the bed flattens the torso, according to a study in Nursing Research, indicating that clinicians need to manage…

Potential treatment for Ebola

A research team has identified potential drug candidates that successfully treated up to 90% of mice exposed to the Ebola virus, according to a…

FDA approves drug for rare lung disease

On May 28, the U.S. Food and Drug Administration (FDA) approved Rapamune (sirolimus), to treat lymphangioleiomyomatosis, a rare, progressive lung disease that…

Potential treatment for Ebola

A research team has identified potential drug candidates that successfully treated up to 90% of mice exposed to the Ebola virus, according…

Poll

Preferred way to get content

What is your preferred way to consume healthcare content?

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.